Reference
Castellino A, et al. Long term follow-up (FU) of lenalidomide plus R-CHOP therapy in patients with newly diagnosed diffuse large b-cell lymphoma (DLBCL): Combined analysis from two phase 2 trials. Journal of Clinical Oncology 36 (Suppl.): No. 15, 20 May 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.15-suppl.7562 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1739, 39 (2019). https://doi.org/10.1007/s40278-019-57679-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57679-6